Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

‘We created a monster’: companies rein in AI usage as costs strain budgets

Amazon, Walmart and Uber are among early adopters that have introduced caps or discouraged wasteful activity

Lessons from Ireland’s Revolut revolution

Financial Times

June 15, 2026

KP George gets jail time, probation in felony money laundering case

Houston Chronicle

June 16, 2026

Ta-Nehisi Coates on The Next Black President

Vanity Fair

June 15, 2026

One City Might Have Just Cracked the Housing Crisis

The New York Times

Zoning

June 15, 2026

InspireMD posts positive CGUARDIANS II data for CGuard Prime TCAR

Posted on June 16, 2026
By Bing News
0 Views
1 min read

InspireMD posts positive CGUARDIANS II data for CGuard Prime TCAR

InspireMD, Inc. NSPR announced positive 30-day results from the CGUARDIANS II clinical trial evaluating its CGuard Prime 80 cm carotid stent implant for use in transcarotid artery revascularization (TCAR) procedures. The study met key safety and efficacy endpoints, reporting a 100% acute device success rate and no deaths, strokes, myocardial infarctions or stent thrombosis within 30 days. The latest data strengthen InspireMD's case for a...